Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 52 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 7815916

    Cloning and expression of HTLV-III DNA

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  2. US 7795389

    Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins

    The Board of Regents of the University of Texas System · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted

  3. US 7771963

    Methods for determining efficacy of chemotherapeutic agents

    Precision Therapeutics, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  4. US 7771729

    Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  5. US 7772259

    1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  6. US 7763590

    Compositions and methods for inhibiting expression of a mutant gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted

  7. US 7759320

    Compositions and methods for inhibiting expression of a gene from the Ebola

    Alnylam Pharmaceuticals, Inc. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  8. US 7754676

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

  9. US 7749978

    Compositions and methods for inhibiting expression of Huntingtin gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  10. US 7745388

    Peptides for activation and inhibition of δPKC

    The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  11. US 7737124

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    The Regents of the University of California · Granted Jun 15, 2010 · Expires Jun 10, 2030

    granted

  12. US 7736652

    Antibody fusion proteins: effective adjuvants of protein vaccination

    The Regents of the University of California · Granted Jun 15, 2010 · Expires Jun 10, 2030

    granted

  13. US 7732167

    Interferon-α/β binding fusion proteins and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

  14. US 7732207

    Method for expression of small antiviral RNA molecules within a cell

    The Regents of the University of California · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

  15. US 7728120

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  16. US 7727970

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus

    Benitec, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  17. US 7723474

    Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted

  18. US 7723322

    Fluoride carrier for positron emission tomography

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted

  19. US 7718629

    Compositions and methods for inhibiting expression of Eg5 gene

    Alnylam Pharmaceuticals, Inc. · Granted May 18, 2010 · Expires May 13, 2030

    granted

  20. US 7709456

    Modulation of gene expression by oligomers targeted to chromosomal DNA

    The Board of Regents of the University of Texas System · Granted May 4, 2010 · Expires Apr 29, 2030

    granted

  21. US 7700274

    Compositions and methods in cancer associated with altered expression of KCNJ9

    Sagres Discovery, Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted

  22. US 7696338

    Immunotoxin fusion proteins and means for expression thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted

  23. US 7691824

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Alnylam Pharmaceuticals, Inc. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

  24. US 7691607

    Expression system of NELL peptide

    The Regents of the University of California · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.